Overview

Postoperative Pain Control in Septum and Sinus Surgery

Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate if the use of acetaminophen round the clock (scheduled doses) will lead to less opiate use in the first week post-operative (after surgery) in sinus/septum surgery patients. Participants will be randomized like a flip of a coin to either the standard of care pain treatment of acetaminophen 325 mg as needed for pain plus opiates (acetaminophen/hydrocodone) as needed for breakthrough pain; OR to the study arm of acetaminophen 650 mg every 6 hours plus opiates (Oxycodone)as needed for breakthrough pain.
Phase:
Phase 4
Details
Lead Sponsor:
William Beaumont Hospitals
Treatments:
Acetaminophen
Acetaminophen, hydrocodone drug combination
Hydrocodone
Oxycodone